ClinVar Miner

Submissions for variant NM_152594.3(SPRED1):c.1149_1150AG[1] (p.Glu384fs) (rs878855228)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000226597 SCV000291521 pathogenic Legius syndrome 2018-08-17 criteria provided, single submitter clinical testing This sequence change deletes 2 nucleotides from exon 7 of the SPRED1 mRNA (c.1151_1152delAG), causing a frameshift at codon 384 and creating a premature translational stop signal in the last exon of the SPRED1 mRNA (p.Glu384Glyfs*5). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the SPROUTY-related domain (SPR) responsible for translocation to the plasma membrane and interaction with the Raf protein. The SPR domain also mediates dimerization of Spred proteins (PMID: 15683364). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature. A different frameshift mutation c.1149_1152del (p.Gly385Ilefs*20) has been observed in several individuals and families with Legius syndrome (PMID: 19920235, 19443465, 21089071, 17704776), which suggests a truncation in the last exon disrupts SPRED1 function and causes disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.